NR3C2 and depressive disorder: Here we found that: (1) the MBCT group did not present significant changes in differential gene expression levels of CRP, IL1-β, MCP1 and NR3C2 and (2) changes in gene expression levels were not correlated with improvements in depression and anxiety symptoms.